⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FBIO News
Fortress Biotech, Inc.
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing
globenewswire.com
FBIO
Form 8-K
sec.gov
FBIOP
FBIO
Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
globenewswire.com
DERM
FBIO
Fortress Biotech to Participate in A.G.P.’s Annual Virtual Healthcare Conference
globenewswire.com
FBIO
Form 8-K
sec.gov
FBIOP
FBIO
Fortress Biotech Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
FBIO
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
DERM
FBIO
Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026
globenewswire.com
DERM
FBIO
Fortress Biotech to Participate in the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference
globenewswire.com
FBIO
Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™
globenewswire.com
FBIO
DERM